459 related articles for article (PubMed ID: 18321465)
21. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
22. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.
Koh A; Lee WK; Chen LJ; Chen SJ; Hashad Y; Kim H; Lai TY; Pilz S; Ruamviboonsuk P; Tokaji E; Weisberger A; Lim TH
Retina; 2012 Sep; 32(8):1453-64. PubMed ID: 22426346
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.
Bashshur ZF; Schakal A; Hamam RN; El Haibi CP; Jaafar RF; Noureddin BN
Arch Ophthalmol; 2007 Oct; 125(10):1357-61. PubMed ID: 17923543
[TBL] [Abstract][Full Text] [Related]
24. A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.
Sivaprasad S; Patra S; DaCosta J; Adewoyin T; Shona O; Pearce E; Chong NV
Ophthalmologica; 2011; 225(4):200-6. PubMed ID: 21293163
[TBL] [Abstract][Full Text] [Related]
25. Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Seidel G; Werner C; Weger M; Steinbrugger I; Haas A
Acta Ophthalmol; 2013 Sep; 91(6):e482-5. PubMed ID: 23786546
[TBL] [Abstract][Full Text] [Related]
26. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia.
Wolf S; Balciuniene VJ; Laganovska G; Menchini U; Ohno-Matsui K; Sharma T; Wong TY; Silva R; Pilz S; Gekkieva M;
Ophthalmology; 2014 Mar; 121(3):682-92.e2. PubMed ID: 24326106
[TBL] [Abstract][Full Text] [Related]
27. Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.
Bressler NM; Chang TS; Varma R; Suñer I; Lee P; Dolan CM; Ward J; Ianchulev T; Fine J
Ophthalmology; 2013 Jan; 120(1):160-8. PubMed ID: 23009891
[TBL] [Abstract][Full Text] [Related]
28. Combination photodynamic therapy and intravitreal ranibizumab in neovascular AMD in a north Indian population: a pilot study.
Kumar A; Gopalakrishnan K; Sinha S
Retina; 2008 Oct; 28(8):1132-7. PubMed ID: 18779720
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
[TBL] [Abstract][Full Text] [Related]
30. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Chaudhary V; Mao A; Hooper PL; Sheidow TG
Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
[TBL] [Abstract][Full Text] [Related]
31. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.
Augustin AJ; Puls S; Offermann I
Retina; 2007 Feb; 27(2):133-40. PubMed ID: 17290193
[TBL] [Abstract][Full Text] [Related]
32. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
[TBL] [Abstract][Full Text] [Related]
34. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
35. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2.
Abraham P; Yue H; Wilson L
Am J Ophthalmol; 2010 Sep; 150(3):315-324.e1. PubMed ID: 20598667
[TBL] [Abstract][Full Text] [Related]
36. [Intravitreal ranibizumab in combination with verteporfin photodynamic therapy in neovascular macular degeneration].
Soucek P; Soucková I
Cesk Slov Oftalmol; 2008 Jul; 64(4):135-40. PubMed ID: 18780651
[TBL] [Abstract][Full Text] [Related]
37. Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin.
Van de Moere A; Sandhu SS; Kak R; Mitchell KW; Talks SJ
Ophthalmology; 2005 Nov; 112(11):1896-903. PubMed ID: 16214216
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
39. Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration.
Ladewig MS; Karl SE; Hamelmann V; Helb HM; Scholl HP; Holz FG; Eter N
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):17-25. PubMed ID: 17701197
[TBL] [Abstract][Full Text] [Related]
40. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.
Slakter JS; Bochow TW; D'Amico DJ; Marks B; Jerdan J; Sullivan EK; Robertson SM; Slakter JS; Sullins G; Zilliox P;
Ophthalmology; 2006 Jan; 113(1):3-13. PubMed ID: 16368146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
